210 related articles for article (PubMed ID: 29263303)
1. Intestinal, but not hepatic, ChREBP is required for fructose tolerance.
Kim M; Astapova II; Flier SN; Hannou SA; Doridot L; Sargsyan A; Kou HH; Fowler AJ; Liang G; Herman MA
JCI Insight; 2017 Dec; 2(24):. PubMed ID: 29263303
[TBL] [Abstract][Full Text] [Related]
2. The Role of Carbohydrate Response Element Binding Protein in Intestinal and Hepatic Fructose Metabolism.
Iizuka K
Nutrients; 2017 Feb; 9(2):. PubMed ID: 28241431
[TBL] [Abstract][Full Text] [Related]
3. Lipogenic transcription factor ChREBP mediates fructose-induced metabolic adaptations to prevent hepatotoxicity.
Zhang D; Tong X; VanDommelen K; Gupta N; Stamper K; Brady GF; Meng Z; Lin J; Rui L; Omary MB; Yin L
J Clin Invest; 2017 Jun; 127(7):2855-2867. PubMed ID: 28628040
[TBL] [Abstract][Full Text] [Related]
4. ChREBP deficiency leads to diarrhea-predominant irritable bowel syndrome.
Oh AR; Sohn S; Lee J; Park JM; Nam KT; Hahm KB; Kim YB; Lee HJ; Cha JY
Metabolism; 2018 Aug; 85():286-297. PubMed ID: 29669261
[TBL] [Abstract][Full Text] [Related]
5. ChREBP-Knockout Mice Show Sucrose Intolerance and Fructose Malabsorption.
Kato T; Iizuka K; Takao K; Horikawa Y; Kitamura T; Takeda J
Nutrients; 2018 Mar; 10(3):. PubMed ID: 29534502
[TBL] [Abstract][Full Text] [Related]
6. ChREBP regulates fructose-induced glucose production independently of insulin signaling.
Kim MS; Krawczyk SA; Doridot L; Fowler AJ; Wang JX; Trauger SA; Noh HL; Kang HJ; Meissen JK; Blatnik M; Kim JK; Lai M; Herman MA
J Clin Invest; 2016 Nov; 126(11):4372-4386. PubMed ID: 27669460
[TBL] [Abstract][Full Text] [Related]
7. A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism.
Fisher FM; Kim M; Doridot L; Cunniff JC; Parker TS; Levine DM; Hellerstein MK; Hudgins LC; Maratos-Flier E; Herman MA
Mol Metab; 2017 Jan; 6(1):14-21. PubMed ID: 28123933
[TBL] [Abstract][Full Text] [Related]
8. Deletion of hepatic carbohydrate response element binding protein (ChREBP) impairs glucose homeostasis and hepatic insulin sensitivity in mice.
Jois T; Chen W; Howard V; Harvey R; Youngs K; Thalmann C; Saha P; Chan L; Cowley MA; Sleeman MW
Mol Metab; 2017 Nov; 6(11):1381-1394. PubMed ID: 29107286
[TBL] [Abstract][Full Text] [Related]
9. Recent insights into the role of ChREBP in intestinal fructose absorption and metabolism.
Lee HJ; Cha JY
BMB Rep; 2018 Sep; 51(9):429-436. PubMed ID: 30158026
[TBL] [Abstract][Full Text] [Related]
10. Liver ChREBP Protects Against Fructose-Induced Glycogenic Hepatotoxicity by Regulating L-Type Pyruvate Kinase.
Shi JH; Lu JY; Chen HY; Wei CC; Xu X; Li H; Bai Q; Xia FZ; Lam SM; Zhang H; Shi YN; Cao D; Chen L; Shui G; Yang X; Lu Y; Chen YX; Zhang WJ
Diabetes; 2020 Apr; 69(4):591-602. PubMed ID: 31974143
[TBL] [Abstract][Full Text] [Related]
11. Fructose malabsorption in ChREBP-deficient mice disrupts the small intestine immune microenvironment and leads to diarrhea-dominant bowel habit changes.
Jang J; Hwang S; Oh AR; Park S; Yaseen U; Kim JG; Park S; Jung Y; Cha JY
Inflamm Res; 2023 Apr; 72(4):769-782. PubMed ID: 36813915
[TBL] [Abstract][Full Text] [Related]
12. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
13. ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome.
Iizuka K; Horikawa Y
Endocr J; 2008 Aug; 55(4):617-24. PubMed ID: 18490833
[TBL] [Abstract][Full Text] [Related]
14. Reduced Nogo expression inhibits diet-induced metabolic disorders by regulating ChREBP and insulin activity.
Zhang S; Guo F; Yu M; Yang X; Yao Z; Li Q; Wei Z; Feng K; Zeng P; Zhao D; Li X; Zhu Y; Miao QR; Iwakiri Y; Chen Y; Han J; Duan Y
J Hepatol; 2020 Dec; 73(6):1482-1495. PubMed ID: 32738448
[TBL] [Abstract][Full Text] [Related]
15. The Roles of Carbohydrate Response Element Binding Protein in the Relationship between Carbohydrate Intake and Diseases.
Iizuka K
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769488
[TBL] [Abstract][Full Text] [Related]
16. Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling.
Softic S; Gupta MK; Wang GX; Fujisaka S; O'Neill BT; Rao TN; Willoughby J; Harbison C; Fitzgerald K; Ilkayeva O; Newgard CB; Cohen DE; Kahn CR
J Clin Invest; 2017 Nov; 127(11):4059-4074. PubMed ID: 28972537
[TBL] [Abstract][Full Text] [Related]
17. Carbohydrate-response-element-binding protein (ChREBP) and not the liver X receptor α (LXRα) mediates elevated hepatic lipogenic gene expression in a mouse model of glycogen storage disease type 1.
Grefhorst A; Schreurs M; Oosterveer MH; Cortés VA; Havinga R; Herling AW; Reijngoud DJ; Groen AK; Kuipers F
Biochem J; 2010 Dec; 432(2):249-54. PubMed ID: 20854262
[TBL] [Abstract][Full Text] [Related]
18. ChREBP refines the hepatic response to fructose to protect the liver from injury.
Hall AM; Finck BN
J Clin Invest; 2017 Jun; 127(7):2533-2535. PubMed ID: 28628039
[TBL] [Abstract][Full Text] [Related]
19. LXRα Regulates Hepatic ChREBPα Activity and Lipogenesis upon Glucose, but Not Fructose Feeding in Mice.
Fan Q; Nørgaard RC; Bindesbøll C; Lucas C; Dalen KT; Babaie E; Itkonen HM; Matthews J; Nebb HI; Grønning-Wang LM
Nutrients; 2017 Jun; 9(7):. PubMed ID: 28661453
[TBL] [Abstract][Full Text] [Related]
20. [Can the hyperactivity of lipogenesis cause hepatic steatosis? A role for ChREBP].
Robichon C; Girard J; Postic C
Med Sci (Paris); 2008 Oct; 24(10):841-6. PubMed ID: 18950580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
